Health & Fitness

Sindh Govt says that Karachi’s deaths are not only linked to Covid-19



Health managers collect samples for calibration of people to test the COVVI -19 Coronavirus in Karachi on September 14, 2020. – AFP

The Sindh Health Department said on Saturday that the allegations of four deaths only allocated to COVID-19 are not accurate.

In a statement, the spokesperson for the provincial health department said the four patients were over 60 and also suffered from other diseases.

He added that all patients were under treatment in a private hospital and faced multiple complications.

The spokesman also said that COVVI-19 was considered a common virus around the world and citing the virus because the only cause of death could cause fear and panic among citizens.

This clarification occurred after at least four people – mainly elderly people with compromise immune systems and pre -existing health problems – apparently died from COVID -19 to Karachi in the midst of a marked increase in cases during the past fortnight, said infection -to -disease officials and experts.

All deaths took place at the AGA Khan University Hospital (AKUH), which reported a constant increase in COVVI -19 admissions – a trend described by experts as “unusual” for this period of the year.

Duhs officials suspect that current infections can be motivated by the JN.1 sub-variant of omicron, a strain known to cause softer symptoms but always capable of causing a serious illness in vulnerable populations. “We opt for the sequencing of genes to determine the exact variant responsible for Karachi infections.”

During the cocovated pandemic, Pakistan used a mixture of vaccines from Chinese, Russian, Europeans and American manufacturers, notably Sinopharm, Sinovac, Cansinobio, Sputnik V, Astrazeneca, Pfizer-Biontech and Moderna. The initial deployment of the vaccine began with front -line workers, followed by the elderly and then the general adult population.

This combination of traditional inactivated inactivated virus vaccines and mRNA -based formulations provided a large immunity shield, which, according to health officials, has helped limit the number of deaths in Pakistan to around 30,000 despite several waves of the virus and the spread of several variants, including Delta and Omicron.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button